Rothwell, Figg, Ernst & Manbeck, PC | USA | 17 Apr 2019
On April 2, 2019, Eli Lilly and Company (“Lilly”) filed a Petition for Post-Grant Review (“PGR”) of Genentech’s U.S. Patent 10,011,654 (“the ’654…
Rothwell, Figg, Ernst & Manbeck, PC | USA | 18 Mar 2019
Over four years ago, in October 2014, Amgen initiated a patent infringement suit against Sanofi and Regeneron regarding biologics for treatment of…
Rothwell, Figg, Ernst & Manbeck, PC | USA | 24 Feb 2019
According to Sandoz, the ʼ997 patent is in the same patent family as U.S. Patent No. 8,940,878 (“the ʼ878 patent”), which Amgen asserted against…
Proskauer Rose LLP | USA | 10 Jan 2019
As we closed the door on 2018, we were met by two surprising decisions—one from a panel of the Second Circuit addressing employer…
Dinsmore & Shohl LLP | USA | 8 Jan 2019
In a recent opinion out of the U.S. District Court for the District of Columbia, U.S. District Court Judge Rudolph Contreras held that the U.S…
Mintz | USA | 2 Jan 2019
The Federal Courts gave the America Hospital Association and 340B covered entities a late Christmas present and in doing so may have dealt a blow to…
Bereskin & Parr LLP | USA | 29 Nov 2018
Recent case law in the United States has changed the landscape for patenting antibodies. In Amgen v Sanofi, 872 F.3d 1367, the Federal Circuit ruled…
Smart & Biggar | Canada | 1 Nov 2018
The Federal Court of Canada has refused Pfizer’s motion to dismiss an action under the Patented Medicines (Notice of Compliance) Regulations (PMNOC…
Smart & Biggar | Canada | 24 Sep 2018
The Federal Court recently dismissed the first motion for summary dismissal brought under Section 6.08 of the amended Patented Medicines (Notice of…
Rothwell, Figg, Ernst & Manbeck, PC | USA | 30 Aug 2018
Earlier this month, Amgen initiated suit against Apotex in the Middle District of Florida, alleging infringement of U.S. Patent No. 9,856,287 (“the…